The combination of sofosbuvir and daclatasvir is well tolerated and extremely effective in treating patients with hepatitis C with severe renal impairment including hemodialysis patinets

被引：0

作者：

Merat, Shahin ^{[1
]}

Sharifi, Amir-Houshang ^{[1
]}

Shayesteh, Ali Akbar ^{[2
]}

Minakari, Mohammad ^{[3
]}

Fattahi, Mohammad Reza ^{[4
]}

Moini, Maryam ^{[4
]}

Roozbeh, Fatemeh ^{[5
]}

Mansour-Ghanaei, Fariborz ^{[6
]}

Afshar, Behrooz ^{[7
]}

Mokhtare, Marjan ^{[8
]}

Amiriani, Taghi ^{[9
]}

Sofian, Masomeh ^{[10
]}

Somi, Mohammad-Hossein ^{[11
]}

Agah, Shahram ^{[8
]}

Maleki, Iradj ^{[5
]}

Latifnia, Maryam ^{[12
]}

Hormati, Ahmad ^{[13
]}

Khoshnia, Masoud ^{[9
]}

Sohrabi, Masoud ^{[8
]}

Malekzadeh, Reza ^{[1
]}

机构：

[1] Univ Tehran Med Sci, Tehran, Iran

[2] Ahvaz Jundishapur Univ Med Sci, Ahvaz, Iran

[3] Isfahan Univ Med Sci, Esfahan, Iran

[4] Shiraz Univ Med Sci, Shiraz, Iran

[5] Mazandaran Univ Med Sci, Sari, Iran

[6] Guilan Univ Med Sci, Rasht, Iran

[7] Hamadan Univ Med Sci, Hamadan, Iran

[8] Iran Univ Med Sci, Tehran, Iran

[9] Golestan Univ Med Sci, Gorgan, Golestan, Iran

[10] Arak Univ Med Sci, Arak, Iran

[11] Tabriz Univ Med Sci, Tabriz, Iran

[12] Sabzevar Univ Med Sci, Sabzevar, Iran

[13] Qom Univ Med Sci, Qom, Iran

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

10.1016/S0618-8278(19)30437-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-162

引用

页码：E233 / E233

页数：1